Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Bosco & Crossy's stock picks,talk area -- Ignore unavailable to you. Want to Upgrade?

To: Crossy who wrote (3342)	5/7/2003 11:16:24 AM
From: Sleepman	Read Replies (1) \| Respond to of 37387

I agree that this is great news. I had been worried for a while when they were delayed with their quarterly report, but it seems like they are on their business plan and we need to wait it out. I wonder is SARS had anything to do with the delay. I suspect that we will see some more approvals for other countries in the future and that this is from where a lot of their near term growth will come. Then,it will be a wait and see how it develops when EPO goes off patent in Europe. I spoke with the company recently,and they seemed happy with the new CEO and where he is planning on taking the company. With great potential is risk, but I do not understand why this company is selling as cheaply as it is. Dan